相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
Kyeung Min Joo et al.
LABORATORY INVESTIGATION (2008)
Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity
Cory Allen et al.
MOLECULAR THERAPY (2008)
Stem Cell Markers in Gliomas
Paola Dell'Albani
NEUROCHEMICAL RESEARCH (2008)
CD133 Is a Marker of Bioenergetic Stress in Human Glioma
Corinne E. Griguer et al.
PLOS ONE (2008)
Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction
Bikul Das et al.
STEM CELLS (2008)
Adenoviruses 16 and CV23 efficiently transduce human low-passage brain tumor and cancer stem cells
Johan Skog et al.
MOLECULAR THERAPY (2007)
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: Role of autophagic, cell death
Hong Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles
Dagmar Beier et al.
CANCER RESEARCH (2007)
Nectin-1 is a marker of thyroid cancer sensitivity to herpes oncolytic therapy
Yu-Yao Huang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas
Georgia Paraskevakou et al.
MOLECULAR THERAPY (2007)
Nectin-1 expression by squamous cell carcinoma is a predictor of herpes oncolytic sensitivity
Zhenkun Yu et al.
MOLECULAR THERAPY (2007)
Expression of MHC I and NK ligands on human CD133(+) glioma cells: possible targets of immunotherapy
Anhua Wu et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype
Andrea Salmaggi et al.
GLIA (2006)
Herpes simplex virus 1 recombinant virions exhibiting the amino terminal fragment of urokinase-type plasminogen activator can enter cells via the cognate receptor
H Kamiyama et al.
GENE THERAPY (2006)
Enhanced nectin-1 expression and herpes oncolytic sensitivity in highly migratory and invasive carcinoma
ZK Yu et al.
CLINICAL CANCER RESEARCH (2005)
Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection
KA Cassady
JOURNAL OF VIROLOGY (2005)
Influence of in vivo growth on human glioma cell line gene expression:: Convergent profiles under orthotopic conditions
K Camphausen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Characterization of a recombinant herpes simplex virus 1 designed to enter cells via the IL13Rα2 receptor of malignant glioma cells
GY Zhou et al.
JOURNAL OF VIROLOGY (2005)
Nectin-1/HveC mediates herpes simplex virus type 1 entry into primary human sensory neurons and fibroblasts
SA Simpson et al.
JOURNAL OF NEUROVIROLOGY (2005)
Variability in infectivity of primary cell cultures of human brain tumors with HSV-1 amplicon vectors
MA Rueger et al.
GENE THERAPY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus
C Krummenacher et al.
VIROLOGY (2004)
STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells
NN Khodarev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Hypoxia is important in the biology and aggression of human glial brain tumors
SM Evans et al.
CLINICAL CANCER RESEARCH (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival
S Harrow et al.
GENE THERAPY (2004)
Herpes simplex virus: receptors and ligands for cell entry
PG Spear
CELLULAR MICROBIOLOGY (2004)
Cancerous stem cells can arise from pediatric brain tumors
HD Hemmati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Engineered herpes simplex virus 1 is dependent on IL13Rα2 receptor for cell entry and independent of glycoprotein D receptor interaction
G Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study
V Papanastassiou et al.
GENE THERAPY (2002)
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
R Rampling et al.
GENE THERAPY (2000)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
JN Parker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Nectin2α (PRR2α or HveB) and nectin2δ are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D
M Lopez et al.
JOURNAL OF VIROLOGY (2000)
分享论文
